Insider · CIK 0001232258
HBM Healthcare Investments (Cayman) Ltd.
Files at: NBRV, NBRV, PRTK. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2017 SForm 4 → | Sep 14, 8:21 pm EDT | Nabriva Therapeutics plcNBRV | 36,608 | $8.56 | $313,415 | 2,334,128 | −1.54% | plan? |
| Aug 31, 2017 SForm 4 → | Sep 5, 8:18 pm EDT | Nabriva Therapeutics plcNBRV | 639 | $9.50 | $6,071 | 2,370,735 | −0.03% | plan? |
| Aug 7, 2017 SForm 4 → | Aug 9, 8:54 pm EDT | Nabriva Therapeutics plcNBRV | 19,803 | $10.50 | $207,932 | 2,371,374 | −0.83% | plan? |
| Jul 28, 2017 SForm 4 → | Aug 1, 9:21 pm EDT | Nabriva Therapeutics plcNBRV | 6,585 | $10.51 | $69,195 | 2,391,177 | −0.27% | plan? |
| Jul 24, 2017 SForm 4 → | Jul 26, 9:03 pm EDT | Nabriva Therapeutics plcNBRV | 160 | $10.50 | $1,680 | 2,397,762 | −0.01% | plan? |
| Jul 19, 2017 SForm 4 → | Jul 24, 9:10 pm EDT | Nabriva Therapeutics plcNBRV | 44,231 | $10.50 | $464,426 | 2,397,922 | −1.81% | plan? late |
| Jul 19, 2017 SForm 4 → | Jul 21, 9:36 pm EDT | Nabriva Therapeutics Legacy plcNBRV | 44,231 | $10.50 | $464,426 | 2,397,922 | −1.81% | plan? |
| Jul 14, 2017 SForm 4 → | Jul 18, 9:03 pm EDT | Nabriva Therapeutics PlcNBRV | 69,854 | $10.51 | $734,264 | 2,442,153 | −2.78% | plan? |
| Jul 11, 2017 SForm 4 → | Jul 13, 9:22 pm EDT | Nabriva Therapeutics PlcNBRV | 57,175 | $10.53 | $602,056 | 2,512,007 | −2.23% | plan? |
| Jul 5, 2017 SForm 4 → | Jul 7, 9:29 pm EDT | Nabriva Therapeutics PlcNBRV | 2,695 | $10.52 | $28,357 | 2,569,182 | −0.10% | plan? |
| Jun 30, 2017 SForm 4 → | Jul 5, 8:58 pm EDT | Nabriva Therapeutics AGNBRV | 13,127 | $10.94 | $143,670 | 2,571,877 | −0.51% | plan? |
| Jun 27, 2017 SForm 4 → | Jun 29, 9:33 pm EDT | Nabriva Therapeutics AGNBRV | 8,558 | $10.96 | $93,804 | 2,585,004 | −0.33% | plan? |
| Jun 1, 2017 SForm 4 → | Jun 5, 9:41 pm EDT | Nabriva Therapeutics AGNBRV | 400 | $11.27 | $4,508 | 2,593,562 | −0.02% | plan? |
| Apr 26, 2017 SForm 4 → | Apr 28, 7:13 pm EDT | Nabriva Therapeutics AGNBRV | 15,939 | $11.02 | $175,712 | 2,593,962 | −0.61% | plan? |
| Apr 21, 2017 SForm 4 → | Apr 25, 7:19 pm EDT | Nabriva Therapeutics AGNBRV | 2,622 | $11.04 | $28,937 | 2,609,901 | −0.10% | plan? |
| Apr 18, 2017 SForm 4 → | Apr 20, 8:29 pm EDT | Nabriva Therapeutics AGNBRV | 23,932 | $11.11 | $265,889 | 2,612,523 | −0.91% | plan? |
| Apr 11, 2017 SForm 4 → | Apr 13, 9:12 pm EDT | Nabriva Therapeutics AGNBRV | 32,831 | $11.24 | $368,919 | 2,636,455 | −1.23% | plan? |
| Apr 6, 2017 SForm 4/A → | Apr 11, 6:04 am EDT | Nabriva Therapeutics AGNBRV | 90,594 | $10.96 | $992,542 | 2,669,286 | −3.28% | plan? |
| Apr 6, 2017 SForm 4 → | Apr 10, 9:38 pm EDT | Nabriva Therapeutics AGNBRV | 90,594 | $10.96 | $992,542 | 185,394 | −32.8% | plan? |
| May 28, 2015 SForm 4 → | Jun 1, 8:36 pm EDT | Paratek Pharmaceuticals, Inc.PRTK | 20,580 | $30.75 | $632,892 | 1,747,680 | −1.16% | plan? |
Reported trades — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.